Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enzymatica Care is a Swedish life science company and a subsidiary of Enzymatica AB, specializing in the development and commercialization of medical devices based on a unique barrier technology. The company's flagship product, ColdZyme, is a mouth spray designed to prevent and treat the common cold by creating a protective barrier in the oral cavity using marine enzymes (Penzyme). This technology, derived from deep-sea cod, works by cleaving viral proteins to prevent them from infecting cells. Enzymatica Care focuses on self-care solutions for respiratory and infectious diseases, leveraging its patented enzyme platform for global expansion through strategic partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enzymatica Care.